Teva Pharmaceutical Industries Limited American Depositary Shares

$35.25
USD
Last updated on --.
24h volume3.72M
24h highest35.7690 USD
24h lowest34.7450 USD
24h Price movement-0.31%

TEVA recent prices

24 Hours
-0.31%-$0.11
30 days
+6.50%+$2.150
60 days
+2.32%+$0.8
90 days
-1.65%-$0.59

Key data

Previous close35.3600 USD
Market cap40.56B USD
Volume3.72M
P/E ratio25.920000
Dividend yield (TTM)0.00%
Dividend amount0.085000 USD
Next ex-dividend dateNov 27, 2017
Next payment dateDec 12, 2017
EPS diluted (TTM)1.3400 USD
Net income (FY)1.55B USD
Revenue (FY)17.35B USD
Last report dateApr 29, 2026

About Teva Pharmaceutical Industries Limited American Depositary Shares

PHARMACEUTICAL PREPARATIONS
HeadquartersTEL AVIV
Employees (FY)32.84K
Revenue per employee (FY)528.26K USD
Net income per employee (FY)47.29K USD
Listed onNew York Stock Exchange
Official website

TEVA conversion tables

TEVATEVA
USDUSD
0.5 TEVA17.62 USD
1 TEVA35.25 USD
5 TEVA176.25 USD
10 TEVA352.5 USD
USDUSD
TEVATEVA
0.5 USD0.014184 TEVA
1 USD0.028369 TEVA
5 USD0.14184 TEVA
10 USD0.28369 TEVA

FAQ

TEVA is trading at $35.25, -0.31% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TEVA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TEVA is currently trading at $35.25, -0.31% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TEVA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TEVA's P/E ratio is currently 25.920000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TEVA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TEVA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Teva Pharmaceutical Industries Limited American Depositary Shares's market cap is currently 40.56B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.72M
24h highest35.7690 USD
24h lowest34.7450 USD
24h Price movement-0.31%
TEVATEVA
USDUSD
Start trade with TEVA Perpetual